Opportunity
SAM #75N98026Q00289
NIH/NCI Procurement of Luminex LX200 IVD System for Biomarker Analysis
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
April 29, 2026
Respond By
May 10, 2026
Identifier
75N98026Q00289
NAICS
334516
The National Institutes of Health (NIH), through the Clinical Trials Correlative Laboratory Core/Center for Cancer Research at the National Cancer Institute (NCI), is seeking to procure a specialized laboratory system for biomarker analysis: - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Clinical Trials Correlative Laboratory Core/Center for Cancer Research - OEM Highlight: - Luminex Corporation is the specified Original Equipment Manufacturer (OEM) - Products/Services Requested: - Luminex LX200 IVD System - Flow-based bead reader platform - Supports high-throughput, multiplexed genomic and proteomic biomarker analysis - Enables detection of up to 100 analytes per reaction - Includes a 21 CFR Part 11 compliance module for regulatory data integrity in clinical trials - Quantity: 1 system - Unique/Notable Requirements: - System must support 21 CFR Part 11 compliance for data integrity in regulated clinical trial environments - Sole-source procurement to Luminex Corporation, but small business capability statements are being accepted - Place of Performance/Delivery: - National Cancer Institute (NCI), Bethesda, Maryland - NIH OLAO contracting office, Bethesda, Maryland
Description
Attachment: Notice of Intent